Richard Saynor, Chief Executive Officer of Sandoz, said: "Biosimilars is the fastest-growing segment of our pipeline as the need of patients and healthcare systems for these critical medicines ...

Sandoz is introducing Wyost (denosumab-bbdz) and Jubbonti (denosumab-bbdz, the first and only interchangeable FDA-approved denosumab biosimilars and are approved to treat all indications of Amgen ...

Basel, July 1, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced the start of construction for a new, state-of-the-art biosimilars ...

Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach Provided by GlobeNewswire Jul 1, 2025, 5:56:13 AM ...

For Immediate Release Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS. Industry: Generic Drugs ...

Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of USD 222 billion over next 10 years Ongoing investment in ...

Novartis started a review of the business in October 2021, after Sandoz had been suffering from pressure on sales and operating profits for several years due mainly to pricing pressures, which ...

Reprint Address Address for reprints: Adriano Arguedas, M.D., Instituto de Atención Pediátrica, P.O. Box 607-1150, San José, Costa Rica. Fax 506-222-0972; E-mail [email protected]. Pediatr ...

Patients were randomized to receive azithromycin oral suspension either as a single 30-mg/kg dose followed by three doses of placebo, or 10 mg/kg once daily for 3 days plus one dose of placebo or ...

Sandoz Elementary School ' s high ranking earned it eligibility to display a U.S. News Best Elementary Schools award badge. Badge eligibility recognizes educational excellence, as described here ...

Sandoz launched Europe’s first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and ...